Anaemia is common in critically ill patients and is often multi-factorial 1 . Approximately 40% of patients admitted to the intensive care unit (ICU) receive a transfusion during their ICU stay 2 . There is increasing concern that a liberal transfusion strategy in the critically ill, where the patient is transfused when the haemoglobin concentration falls below 10.0 g/dl, is associated with increased morbidity and even mortality. Observational studies suggest that blood transfusion is an independent risk factor for mortality [3] [4] [5] and a prospective randomised controlled trial involving 838 patients suggested that a restrictive strategy of red cell transfusion is at least as effective as, and possibly superior to, a liberal transfusion strategy in critically ill patients 6 . Among patients undergoing cardiac surgery, the use of a restrictive perioperative transfusion strategy compared with a more liberal strategy resulted in non-inferior rates of the combined outcome of 30-day all-cause mortality and severe morbidity 7 .
Less well-documented is the timing of red cell transfusion in patients admitted to the ICU. In cases such as severe trauma ward patients, patients presenting to the emergency department and in many surgical patients, blood may be given prior to ICU admission and even prior to the development of critical illness. Furthermore, patients who are discharged from the ICU may also undergo blood transfusion prior to discharge from hospital for a 
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There is growing concern that blood transfusion may be associated with adverse outcomes in critically ill patients. Timing of transfusion in relation to intensive care unit (ICU) stay may be important in designing and understanding transfusion studies. The objective of this study was to determine the timing of red blood cell transfusion in relation to admission to an Australian ICU and to describe associations with transfusion requirements. We undertook a retrospective, observational, single-centre cohort study of all patients admitted to the ICU at The Northern Hospital, Melbourne, Australia, between 1 January and 31 December 2008 in order to measure the timing of transfusion in relation to ICU admission and the demographic and outcome data of the cohort. 674 individual hospital admissions were analysed. Overall, 28% (188/674) of patients admitted to ICU received a red cell transfusion during their hospital stay. A total of 55 (28.5%) patients were transfused either before and/or after ICU discharge but never in the ICU. Thirty-five percent (258/741) of red cell units were transfused outside the ICU. The median number of red cell units transfused was three units per patient (interquartile range 1 to 5). There was no difference between transfused and non-transfused groups in either crude mortality or severity-adjusted mortality. In approximately one-third of ICU patients in our study transfusions occurred before admission to, and/or after discharge from, the ICU. This has implications for designing and interpreting transfusion studies in the ICU and requires confirmation in a multi-centre study.
key Words: intensive care, haematology, blood transfusion variety of reasons. A prospective, observational study involving the ICUs of 18 Australian and New Zealand hospitals in March 2001 showed that the pre and post-ICU transfusion rates were 37.8 and 15.4%, respectively, although the groups were not characterised any further 8 . Furthermore, in 2001 the rate of inappropriate transfusion in Australian and New Zealand ICUs was remarkably low 8 .
Assessment of the timing of blood transfusion in patients admitted to the ICU has important implications for planning a potential randomised controlled trial of this therapy. Patients transfused prior to ICU admission may be excluded from enrolment in such a randomised trial. In addition, if there is a high incidence of transfusion after ICU discharge, differences in the outcomes of the treatment arms of the study may be diminished. Although there are numerous observational studies [8] [9] [10] of transfusion practices in different countries, a comprehensive literature search failed to reveal any that described in detail the timing of transfusions in relation to admissions to intensive care.
The primary objective of this study was to assess the timing of red cell transfusion in relation to admission to the ICU at The Northern Hospital during the 2008 calendar year. The secondary objective was to describe the difference in the baseline demographics and outcomes between transfused and non-transfused patients.
METHODS

Study design and patient eligibility
This was a retrospective, observational, singlecentre cohort study. We collated data on patients who were admitted to the Northern Hospital ICU between 1 January 2008 and 31 December 2008.
Details of hospital and ICU
The Northern Hospital ICU is a mixed general medical and surgical unit in a 325-bed metropolitan university-affiliated teaching hospital without cardiac or neurosurgery, and limited facility for embolism of gastrointestinal haemorrhage, located in Melbourne, Victoria, Australia. The unit operates according to a closed model where only ICU staff can prescribe therapy. Although there was no institutional transfusion protocol in place during the period of the study, there was consensus among intensivists to follow the National Health and Medical Research Council clinical practice guidelines for appropriate use of red blood cells 11 .
Details of data collected
The demographic and diagnosis data were obtained from the ICU electronic database (Microsoft Access 2003, Microsoft, Seattle, WA, USA), which is a mandatory record of all ICU admissions. We obtained details of all blood product administration from the hospital blood bank for the 2008 calendar year. We identified patients who had received red cells during their hospital admission and who had also been admitted to the ICU. We obtained information on the date the red cells were issued. This was compared with the times of ICU admission and discharge to determine the timing of transfusion in relation to ICU admission (before, during, after). Patients who were transfused in more than one of these time periods were classified as 'mixed'.
We collected data on patient age, gender, hospital admission source and reason for ICU admission. Baseline severity of illness data collected included lowest Acute Physiology and Chronic Health Evaluation (APACHE) III score and highest creatinine in the first 24 hours. Outcome data collected included hospital and ICU length-of-stay and mortality. 
Details of data analysis
In patients with more than one ICU admission during a single hospital admission, we used demographic data from the initial ICU admission. Continuous data were summarised as median and interquartile range if they were skewed, or summarised as mean ± standard deviation if approximately normally distributed. Categorical variables were reported as counts and proportions. Differences between groups for continuous variables were analysed by Student's t-test if normally distributed and by kruskal-Wallis test for skewed data. Contingency tables were assessed by chi-square or Fisher's exact tests, as applicable. Standardised mortality ratios were calculated using APACHE III, Simplified Acute Physiology Score III and Mortality Probability Models II predicted mortalities, and reported with Poisson confidence intervals. Multivariate analysis of factors associated with mortality was performed using logistic regression. P values <0.05 were considered to be statistically significant. Statistical software used to analyse data for the study was Strata/IC 10.1 (College Station, TX, USA). No adjustments were made for multiple testing.
RESULTS
Details of patient demographics
During the study period there were 722 ICU admissions, representing 674 individual hospital admissions. There were 674 individuals with single ICU admissions, of whom 43 had multiple ICU admissions. The median (interquartile range [IQR]) age was 66 (50 to 76) for the group overall.
Timing of transfusions
In total, 28% (188/674) of patients admitted to the ICU received a red cell transfusion during their hospital stay. Table 1 shows the timing of transfusion in relation to ICU admission in terms of both episodes of red cell transfusion and number of patients transfused. A total of 55 (28.5%) patients were transfused either before and/or after ICU discharge but never in the ICU. Of those patients receiving blood during two or more of the three time periods (mixed), only two patients did not receive blood in the ICU.
The median number of units (approximately 260 ml/unit) of red cells transfused (including all locations) was three per patient (IQR 1 to 5). When patients transfused in the ICU only were examined, the median was again three units per patient (IQR 2 to 6). Figure 1 shows the distribution of number of patients in relation to the amount of red cell units transfused.
Differences in baseline characteristics between transfused and non-transfused patients
There were a number of differences in the baseline characteristics between transfused and nontransfused patients ( Table 2 ). The hospital admission source for transfused patients was more likely to be from a nursing home (12 [6.4%] vs 7[1.4%]), although the absolute numbers were small. ICU readmission was more common amongst transfused patients (21 [ Table 3 .
Association between transfusion and patient outcomes
Hospital outcomes were different between the groups. Non-transfused patients were more likely to be discharged directly to home with transfused patients more likely to be transferred to another institution (Table 4) .
Crude mortality at ICU discharge (12 [6.4%] vs 41 [8.4%], P=0.37) and hospital discharge (22 [11.2%] vs 71 [14. 9%], P=0.31) between transfused and nontransfused groups, respectively, were not statistically different. The standardised mortality ratios (SMR) were less than one for all three methods and, while the SMR tended to be lower for the transfused group, the confidence intervals were wide and overlapping, again suggesting no difference in mortality ( Table 5 ). SMRs were calculated for transfused and non-transfused patients using APACHE III to adjust mortality for illness severity, and this also demonstrated no difference between the transfused and non-transfused patients.
DISCUSSION
Summary of major findings
We conducted an audit of blood transfusions in ICU patients, with particular focus on the timing of transfusion in relation to ICU admission. We found that 28% of patients admitted to the ICU received a transfusion at some time during their hospital stay, and that 35% of all units transfused in these patients were not administered during the ICU stay.
Comparison with previous studies
To our knowledge no study has previously assessed transfusion in the period prior to ICU admission. However, the cohort receiving red cells in the ICU or after discharge have been observed in greater detail in previous studies 8, 10 . The median number of units transfused in the ICU in this study was three units per patient. This was similar to that of the CRIT study 2 , and higher than the median of two units found in a recent large Australasian ICU study 10 . The transfused group was older than the non-transfused group, had a lower packed cell volume on the first ICU day, as well as a higher creatinine and higher APACHE III risk of death. The hospital length-of-stay and ICU length-of-stay were also longer. These observations are consistent with previous studies 2, [8] [9] [10] .
Transfused patients were more likely to be transferred elsewhere for ongoing care (rehabilitation facility, another institution or nursing home) than to be discharged home. This suggests greater dependency or frailty and this might be a useful outcome to consider in ICU studies, particularly if coupled with quality of life data. An unexpected result of this analysis was the lack of an outcome difference between the transfused and non-transfused group, unlike the findings of previous studies 3, 12, 13 . There was no mortality difference between transfused and non-transfused groups when examined as raw mortality, severity-adjusted mortality or by multivariable logistic regression. The SMRs were less than one for all three methods, with the transfused group tending to be lower; although the confidence intervals for the two groups were wide and overlapping, suggesting no difference in mortality between the two groups. In addition, transfusion was not an independent predictor of increased mortality on multivariable analysis. In this study, the small numbers may also attribute to the lack of mortality difference.
Universal leucodepletion was associated with reduced morbidity and mortality in post cardiac surgical and trauma patients in a Canadian cohort study 14 . Leucodepleted blood has been transfused in Victoria since 1 July 2008 and this may, in part, explain the results.
Implications for clinicians and researchers
Our findings may have implications in the design of future randomised controlled trials looking at outcomes of transfusion. Patients receiving transfusion prior to ICU admission may be excluded for participation in such trials, or further attention may be given when findings are analysed. Perhaps more importantly, patients who are enrolled into a restrictive strategy of transfusion may be liberally transfused after discharge from the ICU.
Post-ICU red cell transfusions increased the total number of units transfused by almost 24% and therefore had a significant impact on the total number of red cells consumed by critically ill patients. This was more than what has been described in the CRIT study (15%). Being a single-centre study, unlike CRIT, could be an explanation for this.
Study strengths and limitations
The major limitation of this study is its retrospective, single-centre design. This limits its generalisability and its ability to provide details regarding indication, triggers for transfusion and specific transfusion complications. However, the intention of this study was to describe the timing of transfusions, not to draw conclusions from the results of outcomes. To our knowledge, the timing of transfusion in relation to admission to the ICU has not been specifically studied, and this information may be useful in developing future studies or clinical trials related to blood transfusion.
CONCLUSION
Our study revealed that more than one-third of ICU patient transfusions occur before admission and after discharge from the ICU. The impact of transfusion timing on clinical outcomes in critical illness remains unknown. The findings of our study require further clarification, preferably in a multi-centre study.
